These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16407714)

  • 21. Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.
    Icks A; Rathmann W; Haastert B; Gandjour A; Holle R; John J; Giani G;
    Diabet Med; 2007 May; 24(5):473-80. PubMed ID: 17381502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective.
    Lindgren P; Lindström J; Tuomilehto J; Uusitupa M; Peltonen M; Jönsson B; de Faire U; Hellénius ML;
    Int J Technol Assess Health Care; 2007; 23(2):177-83. PubMed ID: 17493303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicare's intensive behavioral therapy for obesity: an exploratory cost-effectiveness analysis.
    Hoerger TJ; Crouse WL; Zhuo X; Gregg EW; Albright AL; Zhang P
    Am J Prev Med; 2015 Apr; 48(4):419-25. PubMed ID: 25703178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
    Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
    Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program.
    Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF
    Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial.
    Saito T; Watanabe M; Nishida J; Izumi T; Omura M; Takagi T; Fukunaga R; Bandai Y; Tajima N; Nakamura Y; Ito M;
    Arch Intern Med; 2011 Aug; 171(15):1352-60. PubMed ID: 21824948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
    Palmer AJ; Tucker DM
    Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis.
    Breeze PR; Thomas C; Squires H; Brennan A; Greaves C; Diggle PJ; Brunner E; Tabak A; Preston L; Chilcott J
    Diabet Med; 2017 May; 34(5):632-640. PubMed ID: 28075544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Cost-Effectiveness of a Cluster-Randomized Prenatal Lifestyle Counseling Trial: A Seven-Year Follow-Up.
    Kolu P; Raitanen J; Puhkala J; Tuominen P; Husu P; Luoto R
    PLoS One; 2016; 11(12):e0167759. PubMed ID: 27936083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial.
    Lindström J; Eriksson JG; Valle TT; Aunola S; Cepaitis Z; Hakumäki M; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Mannelin M; Martikkala V; Moltchanov V; Rastas M; Salminen V; Sundvall J; Uusitupa M; Tuomilehto J
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S108-13. PubMed ID: 12819313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.
    Hoerger TJ; Hicks KA; Sorensen SW; Herman WH; Ratner RE; Ackermann RT; Zhang P; Engelgau MM
    Diabetes Care; 2007 Nov; 30(11):2874-9. PubMed ID: 17698614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.
    Lindström J; Peltonen M; Eriksson JG; Aunola S; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2008 May; 31(5):857-62. PubMed ID: 18252900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
    Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
    BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
    Hernan WH; Brandle M; Zhang P; Williamson DF; Matulik MJ; Ratner RE; Lachin JM; Engelgau MM;
    Diabetes Care; 2003 Jan; 26(1):36-47. PubMed ID: 12502656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.
    Lindström J; Louheranta A; Mannelin M; Rastas M; Salminen V; Eriksson J; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2003 Dec; 26(12):3230-6. PubMed ID: 14633807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediabetes and lifestyle modification: time to prevent a preventable disease.
    Tuso P
    Perm J; 2014; 18(3):88-93. PubMed ID: 25102521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Logan Healthy Living Program: a cluster randomized trial of a telephone-delivered physical activity and dietary behavior intervention for primary care patients with type 2 diabetes or hypertension from a socially disadvantaged community--rationale, design and recruitment.
    Eakin EG; Reeves MM; Lawler SP; Oldenburg B; Del Mar C; Wilkie K; Spencer A; Battistutta D; Graves N
    Contemp Clin Trials; 2008 May; 29(3):439-54. PubMed ID: 18055274
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.